Mezlin

   
Google
 
Web NewDrugInformation.com

Mezlin


Drug - Mezlin
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Mezlocillin Sodium Monohydrate
Multiple ingredients are in alphabetical order.

Strength - EQ 4GM BASE/VIAL
The potency of the active ingredient(s), Mezlocillin Sodium Monohydrate. May repeat for multiple part products.

Applicant - BAYER PHARMS
The firm name holding legal responsibility for Mezlin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 062372
The FDA assigned number to Mezlin. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Mezlin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 13, 1982
The date Mezlin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Mezlin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Mezlin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Bayer Pharmaceuticals Corp
The full name of the firm holding legal responsibility for the new application of Mezlin.

Mezlin